These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 10698808)

  • 1. A placebo-controlled study of fluoxetine versus imipramine in the acute treatment of atypical depression.
    McGrath PJ; Stewart JW; Janal MN; Petkova E; Quitkin FM; Klein DF
    Am J Psychiatry; 2000 Mar; 157(3):344-50. PubMed ID: 10698808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gender differences in treatment response to sertraline versus imipramine in chronic depression.
    Kornstein SG; Schatzberg AF; Thase ME; Yonkers KA; McCullough JP; Keitner GI; Gelenberg AJ; Davis SM; Harrison WM; Keller MB
    Am J Psychiatry; 2000 Sep; 157(9):1445-52. PubMed ID: 10964861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pharmacotherapy of depressive illness in adolescents: an open-label comparison of fluoxetine with imipramine-treated historical controls.
    Strober M; DeAntonio M; Schmidt-Lackner S; Pataki C; Freeman R; Rigali J; Rao U
    J Clin Psychiatry; 1999 Mar; 60(3):164-9. PubMed ID: 10192591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do depressed subjects who have failed both fluoxetine and a tricyclic antidepressant respond to the combination?
    Levitt AJ; Joffe RT; Kamil R; McIntyre R
    J Clin Psychiatry; 1999 Sep; 60(9):613-6. PubMed ID: 10520980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized, placebo-controlled trial of paroxetine versus imipramine in depressed HIV-positive outpatients.
    Elliott AJ; Uldall KK; Bergam K; Russo J; Claypoole K; Roy-Byrne PP
    Am J Psychiatry; 1998 Mar; 155(3):367-72. PubMed ID: 9501747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patients with severe depression may benefit from buspirone augmentation of selective serotonin reuptake inhibitors: results from a placebo-controlled, randomized, double-blind, placebo wash-in study.
    Appelberg BG; Syvälahti EK; Koskinen TE; Mehtonen OP; Muhonen TT; Naukkarinen HH
    J Clin Psychiatry; 2001 Jun; 62(6):448-52. PubMed ID: 11465522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A double-blind comparison of nefazodone, imipramine, and placebo in major depression.
    Fontaine R; Ontiveros A; Elie R; Kensler TT; Roberts DL; Kaplita S; Ecker JA; Faludi G
    J Clin Psychiatry; 1994 Jun; 55(6):234-41. PubMed ID: 8071277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reboxetine versus fluoxetine: an overview of efficacy and tolerability.
    Massana J
    J Clin Psychiatry; 1998; 59 Suppl 14():8-10. PubMed ID: 9818624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the effects of fluoxetine, imipramine and placebo on personality in atypical depression.
    Agosti V; McGrath PJ
    J Affect Disord; 2002 Sep; 71(1-3):113-20. PubMed ID: 12167507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of response to acute treatment of chronic and double depression with sertraline or imipramine.
    Hirschfeld RM; Russell JM; Delgado PL; Fawcett J; Friedman RA; Harrison WM; Koran LM; Miller IW; Thase ME; Howland RH; Connolly MA; Miceli RJ
    J Clin Psychiatry; 1998 Dec; 59(12):669-75. PubMed ID: 9921701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcomes of initial antidepressant drug choice in a "real world" randomized trial.
    Simon GE; Heiligenstein J; Revicki D; VonKorff M; Katon WJ; Ludman E; Grothaus L; Wagner E
    Arch Fam Med; 1999; 8(4):319-25. PubMed ID: 10418538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The treatment of chronic depression, part 2: a double-blind, randomized trial of sertraline and imipramine.
    Keller MB; Gelenberg AJ; Hirschfeld RM; Rush AJ; Thase ME; Kocsis JH; Markowitz JC; Fawcett JA; Koran LM; Klein DN; Russell JM; Kornstein SG; McCullough JP; Davis SM; Harrison WM
    J Clin Psychiatry; 1998 Nov; 59(11):598-607. PubMed ID: 9862606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness and cost-effectiveness of antidepressant treatment in primary health care: a six-month randomised study comparing fluoxetine to imipramine.
    Serrano-Blanco A; Gabarron E; Garcia-Bayo I; Soler-Vila M; Caramés E; Peñarrubia-Maria MT; Pinto-Meza A; Haro JM;
    J Affect Disord; 2006 Apr; 91(2-3):153-63. PubMed ID: 16458976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized, placebo-controlled trial of fluoxetine for acute treatment of minor depressive disorder.
    Judd LL; Rapaport MH; Yonkers KA; Rush AJ; Frank E; Thase ME; Kupfer DJ; Plewes JM; Schettler PJ; Tollefson G
    Am J Psychiatry; 2004 Oct; 161(10):1864-71. PubMed ID: 15465984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A double-blind, randomized, group-comparative study of the tolerability and efficacy of 6 weeks' treatment with mirtazapine or fluoxetine in depressed Chinese patients.
    Hong CJ; Hu WH; Chen CC; Hsiao CC; Tsai SJ; Ruwe FJ
    J Clin Psychiatry; 2003 Aug; 64(8):921-6. PubMed ID: 12927007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TCAs or SSRIs as initial therapy for depression?
    Tyra JM; Greenawald MH
    J Fam Pract; 1999 Nov; 48(11):845-6. PubMed ID: 10907616
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of the effectiveness of reboxetine versus fluoxetine in patients with atypical depression: a single-blind, randomized clinical trial.
    Taner E; Demir EY; Cosar B
    Adv Ther; 2006; 23(6):974-87. PubMed ID: 17276965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nortriptyline versus fluoxetine in the treatment of depression and in short-term recovery after stroke: a placebo-controlled, double-blind study.
    Robinson RG; Schultz SK; Castillo C; Kopel T; Kosier JT; Newman RM; Curdue K; Petracca G; Starkstein SE
    Am J Psychiatry; 2000 Mar; 157(3):351-9. PubMed ID: 10698809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mirtazapine: efficacy and tolerability in comparison with fluoxetine in patients with moderate to severe major depressive disorder. Mirtazapine-Fluoxetine Study Group.
    Wheatley DP; van Moffaert M; Timmerman L; Kremer CM
    J Clin Psychiatry; 1998 Jun; 59(6):306-12. PubMed ID: 9671343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double-blind, placebo-controlled study comparing the effects of sertraline versus amitriptyline in the treatment of major depression.
    Lydiard RB; Stahl SM; Hertzman M; Harrison WM
    J Clin Psychiatry; 1997 Nov; 58(11):484-91. PubMed ID: 9413414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.